Eye Tracking as a Tool for Detecting Alzheimer's Disease in People With Down Syndrome
Journal of Intellectual Disability Research · 2025
DOI: 10.1111/jir.13214 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Intellectual Disability Research, 2025. Verfasst von Brianna Piro-Gambetti und 13 weiteren Autor:innen. Beteiligte Einrichtung: Waisman Center, University of Wisconsin-Madison, Madison, Wisconsin, USA. Hauptthemen laut MEDLINE: Down Syndrome, Alzheimer Disease, Eye-Tracking Technology, Cognitive Dysfunction. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NIH HHS, NICHD NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
Background
Adults with Down syndrome (DS) experience an increased risk of Alzheimer's disease ( AD ). Valid cognitive assessments for adults with DS with severe/profound intellectual disability (ID) are needed. It is unclear whether eye tracking is feasible for detecting AD in DS.
Method
Fifty‐three adults with DS completed a visual paired comparison (VPC) task, a battery of cognitive measures, and underwent PET scanning. Study partners reported on the participant's dementia symptoms. Bivariate correlations assessed associations between eye‐tracking metrics and AD ‐related pathology and symptomatology. Analyses included the full sample ( n = 53) and a subgroup with an IQ ≤ 45 ( n = 33).
Results
Greater fixation duration during the habituation phase was associated with better cognitive performance on the Modified Cued Recall Test (mCRT) (intrusions: r = −0.39, p = 0.011) and less PET tau ( r = −0.47, p = 0.014). Larger saccadic amplitudes during the test phase were associated with younger age ( r = −0.45, p < 0.001), better cognitive performance on the mCRT (total: r = 0.31, p = 0.041; intrusions: r = −0.33, p = 0.032) and less PET Aβ ( r = −0.40, p = 0.025). Greater preference to fixate on the novel image was associated with fewer dementia symptoms (count: r = −0.44, p = 0.002; duration: r = −0.38, p = 0.009). This pattern of significance remained for the subgroup with lower IQ scores.
Conclusion
The VPC task is a potentially useful method for assessing AD ‐related cognitive impairments in adults with DS across varying ID levels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Waisman Center, University of Wisconsin-Madison, Madison, Wisconsin, USA.
- Department of Psychology, New York State Institute for Basic Research in Developmental Disabilities, New York, New York, USA.
- Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- Department of Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- Department of Human Development and Family Studies, University of Wisconsin-Madison, Madison, Wisconsin, USA.
ORCID-Profile: Brianna Piro-Gambetti, Victoria L Fleming, Emily Schworer, Sigan L Hartley
Förderung
- NIA NIH HHS
- NIH HHS
- NICHD NIH HHS
- National Institutes of Health
Zitieren
APA
Piro-Gambetti, B., Krinsky-McHale, S., Kovacs, C., Handen, B., Christian, B., Laymon, C. M., Minhas, D., Luo, W., Yoon, D. M., Fleming, V. L., Schworer, E., Kirkorian, H., Hartley, S. L., & Alzheimer Biomarkers Consortium‐Down Syndrome (2025). Eye Tracking as a Tool for Detecting Alzheimer's Disease in People With Down Syndrome. Journal of Intellectual Disability Research. https://doi.org/10.1111/jir.13214
Vancouver
Piro-Gambetti B, Krinsky-McHale S, Kovacs C, Handen B, Christian B, Laymon CM, et al. Eye Tracking as a Tool for Detecting Alzheimer's Disease in People With Down Syndrome. Journal of Intellectual Disability Research. 2025. doi:10.1111/jir.13214
BibTeX
@article{PiroGambetti2025,
author = {Piro-Gambetti, Brianna and Krinsky-McHale, Sharon and Kovacs, Cynthia and Handen, Benjamin and Christian, Bradley and Laymon, Charles M and Minhas, Davneet and Luo, Weiquan and Yoon, Dasoo Milton and Fleming, Victoria L and Schworer, Emily and Kirkorian, Heather and Hartley, Sigan L and Alzheimer Biomarkers Consortium‐Down Syndrome, Alzheimer Biomarkers Consortium‐Down Syndrome},
title = {Eye Tracking as a Tool for Detecting Alzheimer's Disease in People With Down Syndrome},
journal = {Journal of Intellectual Disability Research},
year = {2025},
doi = {10.1111/jir.13214}
}
EUVIMED